PIK3CA dependence and sensitivity to therapeutic targeting in urothelial carcinoma

被引：0
|
作者：
R. L. Ross
H. R. McPherson
L. Kettlewell
S. D. Shnyder
C. D. Hurst
O. Alder
M. A. Knowles
机构：
[1] Section of Experimental Oncology,
[2] Leeds Institute of Cancer and Pathology,undefined
[3] St James’s University Hospital,undefined
[4] Institute of Cancer Therapeutics,undefined
[5] University of Bradford,undefined
来源：
BMC Cancer | / 16卷
关键词：
PIK3CA; PI3K signaling; Bladder cancer; Urothelium;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] PIK3CA dependence and sensitivity to therapeutic targeting in urothelial carcinoma
    Ross, R. L.
    McPherson, H. R.
    Kettlewell, L.
    Shnyder, S. D.
    Hurst, C. D.
    Alder, O.
    Knowles, M. A.
    [J]. BMC CANCER, 2016, 16
  • [2] Targeting PIK3CA pathway
    Baselga, J.
    [J]. BREAST, 2015, 24 : S10 - S10
  • [3] PIK3CA gene mutational analysis in urothelial carcinoma of urinary bladder
    Murphy, K.
    Jadallah, S.
    Hansel, D.
    Cohen, J.
    Toubaji, A.
    Netto, G. J.
    [J]. LABORATORY INVESTIGATION, 2008, 88 : 172A - 172A
  • [4] PIK3CA gene mutational analysis in urothelial carcinoma of urinary bladder
    Murphy, K.
    Jadallah, S.
    Hansel, D.
    Cohen, J.
    Toubaji, A.
    Netto, G. J.
    [J]. MODERN PATHOLOGY, 2008, 21 : 172A - 172A
  • [5] PIK3CA gene mutational analysis in urothelial carcinoma of urinary bladder
    Netto, George J.
    Jadallah, S.
    Hansel, D.
    Cohen, J.
    Murphy, K.
    [J]. JOURNAL OF UROLOGY, 2008, 179 (04): : 319 - 319
  • [6] PIK3CA mutations in nasopharyngeal carcinoma
    Or, YYY
    Hui, ABY
    To, KF
    Lam, CNY
    Lo, KW
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (04) : 1065 - 1067
  • [7] Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA
    Chandran, Smita S.
    Ma, Jiaqi
    Klatt, Martin G.
    Dundar, Friederike
    Bandlamudi, Chaitanya
    Razavi, Pedram
    Wen, Hannah Y.
    Weigelt, Britta
    Zumbo, Paul
    Fu, Si Ning
    Banks, Lauren B.
    Yi, Fei
    Vercher, Enric
    Etxeberria, Inaki
    Bestman, Watchain D.
    Da Cruz Paula, Arnaud
    Aricescu, Ilinca S.
    Drilon, Alexander
    Betel, Doron
    Scheinberg, David A.
    Baker, Brian M.
    Klebanoff, Christopher A.
    [J]. NATURE MEDICINE, 2022, 28 (05) : 946 - +
  • [8] Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA
    Smita S. Chandran
    Jiaqi Ma
    Martin G. Klatt
    Friederike Dündar
    Chaitanya Bandlamudi
    Pedram Razavi
    Hannah Y. Wen
    Britta Weigelt
    Paul Zumbo
    Si Ning Fu
    Lauren B. Banks
    Fei Yi
    Enric Vercher
    Inaki Etxeberria
    Watchain D. Bestman
    Arnaud Da Cruz Paula
    Ilinca S. Aricescu
    Alexander Drilon
    Doron Betel
    David A. Scheinberg
    Brian M. Baker
    Christopher A. Klebanoff
    [J]. Nature Medicine, 2022, 28 : 946 - 957
  • [9] Relationship between RAS, BRAF, PIK3CA and location of primary tumor in urothelial carcinoma
    Kim, Young Saing
    Lee, Sang-Cheol
    Hwang, In Gyu
    Lee, Su Jin
    Park, Se Hoon
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [10] Mutant PIK3CA in AML and sensitivity to therapy
    Libra, Massimo
    Ligresti, Giovanni
    Pezzino, Franca Maria
    Basecke, Jorg
    Steelman, Linda S.
    Abrams, Stephen L.
    McCubrey, James A.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2012, 30 : S56 - S56
12345